-
News | 2023.04.25
Malaria: improving blood filtration by the spleen to stop the disease transmission
Malaria is a disease transmitted to humans by a mosquito bite, itself infected with a parasite. This parasite settles in the liver, then infects the red blood cells and destroys them. A Université Paris Cité - Inserm team, led by Prof. Pierre Buffet, Medical Vice-President of the Institut Pasteur, identifies two drugs likely to increase the efficiency of blood filtration by the spleen. This can...
-
News | 2025.02.10
The Institut Pasteur and AlterDiag announce the signature of a strategic partnership on research and development of next generation rapid diagnostic technologies
Through this long-term strategic partnership agreement, the Institut Pasteur and AlterDiag will carry out research and development projects to develop new single-domain antibodies (VHH) -based rapid diagnostic tests using lateral flow immunochromatography, with the aim of strengthening the fight against infectious diseases. Scientific and technological collaboration to meet global health...
-
News | 2025.05.30
Institut Pasteur deploys MinoSuiteTM “Pioneer” platform from startup Minos Biosciences, developing next-generation cell analysis technology
With the deployment of its MinoSuiteTM Pioneer platform at the Institut Pasteur, within the Dynamics of Host-Pathogen Interactions unit, headed by Dr. Jost Enninga, deep-tech startup Minos Biosciences has officially launched its Early Access Program. The strategic collaboration between Minos Biosciences and the teams of Jost ENNINGA and Milena HASAN from the Institut Pasteur, partially funded by...
-
Article | 2025.07.09
Virology
Fighting viral infections that affect human health.
-
Document de presse | 2020.07.15
Type 1 Interferon deficiency: A blood based Signature for Detecting Patients at risk of severe Covid-19 for a therapeutic approach
Which patients will develop a severe form of Covid-19? This is a key question that needs to be answered to improve the individual management and prognosis of patients. In a study published in Science on July 13, teams from AP-HP, Inserm, Université of Paris, Institut Pasteur and Institut Imagine describe a unique and unexpected immunological phenotype in severe and critical patients, consisting...
-
Article | 2019.08.06
Vaccinology and Immunotherapy Initiative: Innovation – Vaccine Candidates
The Institut Pasteur has a distinguished history of vaccine development as a means to improve global health. A stronghold of the Institut Pasteur in vaccines is the development of novel technologies for vaccine design and delivery with several candidates currently under clinical evaluation, either licensed to development and commercialization partners or under Institut Pasteur sponsorship.
-
Article | 2025.02.20
MD-PhD Program
The Institut Pasteur MD-PhD program is designed to bridge the gap between fundamental, applied research and clinical practice, equipping physicians with the skills needed to tackle the increasingly complex healthcare challenges of today. This program offers opportunities for medical students and doctors to improve patient care and in parallel foster innovation in medical sciences.
-
Document de presse | 2016.08.29
Alzheimer's: nicotinic receptors as a new therapeutic target
Several scientific studies have indicated that nicotine may be beneficial for memory function. Scientists from the Institut Pasteur and the CNRS set out to shed further light on the properties attributed to nicotine – which is known to have an adverse effect on health – by determining the precise structure of the nicotinic receptors in the hippocampus region of the brain. Using mouse...
-
Document de presse | 2015.12.21
The mechanism of an AIDS vaccine candidate filmed in vivo
Using innovative technology, scientists from the Institut Pasteur and Inserm have filmed in vivo the process by which an AIDS vaccine candidate, developed by the French Vaccine Research Institute and the ANRS, triggers the immune response. This previously unseen footage clearly shows how the vaccine recruits the immune cells needed to destroy infected cells. These results, published in the...
-
Document de presse | 2014.08.27
Potential strategies for limiting the hepatitis C epidemic in Egypt
In the fight against hepatitis C, directing preventive and curative interventions towards sufferers of chronic diseases requiring regular medical care would be an effective means of reducing transmission of the hepatitis C virus (HCV) in Egypt, and undoubtedly also in other countries with limited resources. This theory has arisen from a mathematical modeling study carried out as part of the ANRS...